Related Experiment Video
Updated: Jun 29, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Advances in the management of pediatric central nervous system tumors
Shaker Abdullah1, Ibrahim Qaddoumi, Eric Bouffet
1Department of Oncology, King Abdulaziz Medical City-Jeddah, Jeddah, Kingdom of Saudi Arabia.
Abstract:
Central nervous system tumors are the most common pediatric solid tumors and a leading cause of cancer-related mortality and morbidity in this age group. Survival rates have improved significantly over the last decades for most of the tumor types, as a consequence of improvements in neuroimaging, neurosurgery and neuroanesthesia, radiation oncology, and medical oncology. The complexity of the management of these patients requires a multidisciplinary approach and has led to the emergence of a new subspecialty of pediatric neuro-oncologists who are dedicated to the management and follow-up of this population. This review highlights the most critical advances in the diagnostic and treatment modalities of pediatric brain tumors. A specific review of the most common tumor types discusses treatment options, controversies, and ongoing developments, with an emphasis on cooperative trials.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Treatment Resistant Cancers
Treatment Resistent Cancers
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pharmacokinetics in Pediatric Patients: Drug Metabolism

